Association of a CD44s-v5-v6 Null Phenotype with Advanced Stage Cholangiocarcinoma: A Preliminary Study.

Cancers (Basel) · 2025 · PMC12785040 · PMID 41514534

Europe PMC DOI

hedged sentence

0.2530

closest p · 5.1× alpha

0.2530

boldest claim

The sentences

did not reach statistical significancep = 0.253not close (p > 0.1)

This indicates that patients retaining CD44 expression had a reduced risk of death compared to the Null group (a protective trend), although this did not reach statistical significance ( p = 0.253) due to the limited sample size. 4.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.